ATLAS OF PET-CT, A Quick Guide to Image Interpretation Ignasi Carrió Book Review 05 December 2019 Pages: 515 - 516
Radiology and nuclear medicine: advancing together in the era of precision medicine Arturo ChitiYves Menu Editorial 15 January 2020 Pages: 517 - 518
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies Frederik A. VerburgMartha HoffmannMarkus Luster Editorial 05 December 2019 Pages: 519 - 522
18F-FDG PET/CT in patients with post-transplant lymphoproliferative disorders: so far so good Giorgio TregliaLuca Ceriani Editorial 04 September 2019 Pages: 523 - 524
Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma Paulo Schiavom Duarte Letter to the Editor 18 November 2019 Pages: 525 - 526
18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines! Giorgio TregliaLuca Giovanella Letter to the Editor 21 November 2019 Pages: 527 - 528
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield F. M. Montes de JesusT. C. KweeW. Noordzij Original Article Open access 24 August 2019 Pages: 529 - 536
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT Qingqing PanXinxin CaoFang Li Original Article 27 November 2019 Pages: 537 - 546
Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients Sayak ChoudhuryArchi AgrawalVenkatesh Rangarajan Original Article 09 November 2019 Pages: 547 - 553
Variations in radioiodine ablation: decision-making after total thyroidectomy O. MaasF. ForrerP. M. Putora Original Article 09 November 2019 Pages: 554 - 560
Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study Seong Young KwonSang-Woo LeeKorean Society of Nuclear Medicine (KSNM) Thyroid Cancer Clinical Trial Network (CTN) Retrospective Cohort Study Group Original Article 10 December 2019 Pages: 561 - 571
Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas Diego Alfonso López-MoraMarina SizovaIgnasi Carrió Original Article 09 January 2020 Pages: 572 - 578
[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 Cristina NanniLucia ZanoniDavid M. Schuster Guidelines 11 December 2019 Pages: 579 - 591
18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer Christos SachpekidisA. Afshar-OromiehA. Dimitrakopoulou-Strauss Original Article 14 November 2019 Pages: 592 - 602
Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT Yu ZhaoAndrei GafitaKuangyu Shi Original Article 07 December 2019 Pages: 603 - 613
Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison Ian AlbertsGeorge PrenosilAli Afshar-Oromieh Original Article 02 December 2019 Pages: 614 - 623
68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer—a modified protocol compared with the common protocol Fabian HauptLotte DijkstraAli Afshar-Oromieh Original Article 01 November 2019 Pages: 624 - 631
The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients Cem OnalOzan Cem GulerAli Fuat Yapar Original Article 15 November 2019 Pages: 632 - 641
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia Ian AlbertsChristos SachpekidisAli Afshar-Oromieh Original Article 21 December 2019 Pages: 642 - 651
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer Daniela A. FerraroHelena I. Garcia SchülerIrene A. Burger Original Article 04 December 2019 Pages: 652 - 664
Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer Otto EttalaSimona MalaspinaJukka Kemppainen Original Article Open access 26 December 2019 Pages: 665 - 673
The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer Meghana KulkarniSimon HughesGary J. R. Cook Original Article Open access 23 December 2019 Pages: 674 - 686
New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide Florian RosarSebastian DewesSamer Ezziddin Short Communication 03 January 2020 Pages: 687 - 694
The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up Johanna Maffey-SteffanLorenza ScarpaIrene Virgolini Original Article Open access 27 November 2019 Pages: 695 - 712
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks Sazan RasulMarcus HackerAlexander R. Haug Original Article Open access 28 November 2019 Pages: 713 - 720
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience Fadi KhreishNiklas EbertSamer Ezziddin Original Article 22 November 2019 Pages: 721 - 728
Planar scan vs. SPECT/low-dose CT for estimating split renal function by 99mTc-DMSA scintigraphy in children Michala Holm ReichkendlerRonan M. G. BergLise Borgwardt Short Communication 15 November 2019 Pages: 729 - 733
Extranodal involvement of multiple organs in diffuse large B cell lymphoma detected on 18F-FDG PET/CT Tianbin SongRong RongJie Lu Image of the Month 08 January 2020 Pages: 734 - 735
Isolated involvement of thyroid gland by IgG4-related disease revealed by 18F-FDG PET/CT Yuanyuan JiangGuozhu HouWuying Cheng Image of the Month 25 November 2019 Pages: 736 - 737
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy Bart de KeizerKamil G. LabanRachel Kalmann Image of the Month Open access 18 November 2019 Pages: 738 - 739
Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up Johanna Maffey-SteffanLorenza ScarpaIrene Virgolini Correction 20 December 2019 Pages: 740 - 740